Trials / Unknown
UnknownNCT04922918
Ligilactobacillus Salivarius MP101 for Elderly in a Nursing Home
Administration of Ligilactobacillus Salivarius MP101 in an Elderly Nursing Home During the COVID Pandemics
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Universidad Complutense de Madrid · Academic / Other
- Sex
- All
- Age
- 74 Years – 98 Years
- Healthy volunteers
- Accepted
Summary
The objective of this work was to investigate the effect of Ligilactobacillus salivarius MP101 on the functional (Barthel index), cognitive (GDS/FAST) and nutritional (MNA) status, and on the nasal and fecal inflammatory profiles of elderly living in a nursing home highly affected by COVID-19.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Ligilactobacillus salivarius MP101 | Administration of the strain through a fermented milk |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-06-24
- Completion
- 2021-07-01
- First posted
- 2021-06-11
- Last updated
- 2021-06-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04922918. Inclusion in this directory is not an endorsement.